HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitigation of acrylamide-induced behavioral deficits, oxidative impairments and neurotoxicity by oral supplements of geraniol (a monoterpene) in a rat model.

Abstract
In the recent past, several phytoconstituents are being explored for their potential neuromodulatory effects in neurological diseases. Repeated exposure of acrylamide (ACR) leads to varying degree of neuronal damage in experimental animals and humans. In view of this, the present study investigated the efficacy of geraniol (GE, a natural monoterpene) to mitigate acrylamide (ACR)-induced oxidative stress, mitochondrial dysfunction and neurotoxicity in a rat model and compared its efficacy to that of curcumin (CU, a spice active principle with multiple biological activities). ACR administration (50mg/kg bw, i.p. 3times/week) for 4weeks to growing rats caused typical symptoms of neuropathy. ACR rats provided with daily oral supplements of phytoconstituents (GE: 100mg/kg bw/d; CU: 50mg/kg bw/d, 4weeks) exhibited marked improvement in behavioral tests. Both phytoconstituents markedly attenuated ACR-induced oxidative stress as evidenced by the diminished levels of reactive oxygen species, malondialdehyde and nitric oxide and restored the reduced glutathione levels in sciatic nerve (SN) and brain regions (cortex - Ct, cerebellum - Cb). Further, both phytoconstituents effectively diminished ACR-induced elevation in cytosolic calcium levels in SN and Cb. Furthermore, diminution in the levels of oxidative markers in the mitochondria was associated with elevation in the activities of antioxidant enzymes. While ACR mediated elevation in the acetylcholinesterase activity was reduced by both actives, the depletion in dopamine levels was restored only by CU in brain regions. Taken together our findings for the first time demonstrate that the neuromodulatory propensity of GE is indeed comparable to that of CU and may be exploited as a therapeutic adjuvant in the management of varied human neuropathy conditions.
AuthorsSathya N Prasad, Muralidhara
JournalChemico-biological interactions (Chem Biol Interact) Vol. 223 Pg. 27-37 (Nov 05 2014) ISSN: 1872-7786 [Electronic] Ireland
PMID25199698 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Acyclic Monoterpenes
  • Antioxidants
  • Neuroprotective Agents
  • Terpenes
  • Acrylamide
  • Curcumin
  • geraniol
Topics
  • Acrylamide (toxicity)
  • Acyclic Monoterpenes
  • Administration, Oral
  • Animals
  • Antioxidants (metabolism)
  • Behavior, Animal (drug effects)
  • Brain (drug effects, metabolism)
  • Curcumin (administration & dosage, pharmacology)
  • Disease Models, Animal
  • Humans
  • Male
  • Mitochondria (drug effects, metabolism)
  • Neuroprotective Agents (administration & dosage, pharmacology)
  • Neurotoxicity Syndromes (etiology, physiopathology, prevention & control)
  • Oxidative Stress (drug effects)
  • Rats
  • Rats, Wistar
  • Sciatic Nerve (drug effects, metabolism)
  • Terpenes (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: